Open clinical trial of the use of antioxidants and pentoxifylline as adjunctive therapy to improve the prognosis of patients with pneumonia and septic shock due to COVID-19.

  • Funded by Consejo Nacional de Ciencia y Tecnología (CONACYT)
  • Total publications:3 publications

Grant number: 312167

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    Consejo Nacional de Ciencia y Tecnología (CONACYT)
  • Principal Investigator

    N/A

  • Research Location

    Mexico
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Research, Development And Innovation Of Effective And Affordable Therapeutic Alternatives

Publicationslinked via Europe PMC

N-Acetyl Cysteine Restores the Diminished Activity of the Antioxidant Enzymatic System Caused by SARS-CoV-2 Infection: Preliminary Findings.

Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the NFE2L2/KEAP1 Polymorphisms in Regulating SARS-CoV-2 Infection.

Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19.